Drug Price Regulation, B.C. Reg. 344/2012
Section 6
Reference drug program
Cite as Drug Price Regulation, B.C. Reg. 344/2012, s. 6 · last amended March 1, 2026 · read from BC Laws on November 17, 2026
The text
(1) The following are reference drug categories for the purposes of the reference drug program:
(a) angiotensin converting enzyme inhibitors;
(b) angiotensin receptor blockers;
(c) dihydropyridine calcium channel blockers;
(d) histamine-2 receptor antagonists;
(e) hydroxyl-3-methylglutaryl-coenzyme A reductase inhibitors;
(f) non-steroidal anti-inflammatory drugs;
(g) oral nitrates;
(h) proton pump inhibitors.
(2) The minister may, for each category,
(a) determine which drugs are included,
(b) designate one or more drugs as reference drugs, and
(c) designate one drug as the reference drug comparator.
(3) A drug may be designated as a reference drug if the minister is of the opinion that the drug is at least as clinically efficacious or cost-effective as other drugs in the reference drug category.
(4) The minister may designate any of the following as the reference drug comparator:
(a) the reference drug that, in the opinion of the minister, is the most cost-effective of the reference drugs in the reference drug category;
(b) the drug that was designated before April 1, 2013, as the reference drug comparator for the reference drug category;
(c) the drug, in the reference drug category, that, in the opinion of the minister, will best serve the public interest if designated as the reference drug comparator for the reference drug category.
(5) The minister must determine the daily therapeutic dose of the reference drug comparator, the daily therapeutic dose being
(a) the typical dose that is prescribed, and
(b) the number of doses that a beneficiary would typically receive each day.
(6) The minister may change or cancel a determination or designation made under this section.
(7) A change or cancellation under subsection (6) may be made at any time without notice to anyone or an opportunity to be heard.
(8) The minister must publish on the website of the ministry of the minister a list of all of the following for each reference drug category:
(a) the drugs that are included;
(b) the drugs that have been designated as reference drugs;
(c) the drug that has been designated as the reference drug comparator and the applicable daily therapeutic dose;
(d) the maximum daily amount the minister may pay under the Act for a non-reference drug, as determined under section 9 [maximum payment for non-reference drugs].
Read the Drug Price Regulation on BC Laws ↗
Made under Pharmaceutical Services Act, SBC 2012, c. 22.